Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Douglas Buckley"'
Autor:
Marie O’Farrell, Greg Duke, Richard Crowley, Douglas Buckley, Eduardo B. Martins, Dipankar Bhattacharya, Scott L. Friedman, George Kemble
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-16 (2022)
Abstract Fatty acid synthase (FASN) is an attractive therapeutic target in non-alcoholic steatohepatitis (NASH) because it drives de novo lipogenesis and mediates pro-inflammatory and fibrogenic signaling. We therefore tested pharmacological inhibiti
Externí odkaz:
https://doaj.org/article/b33eeb880fcb45fca9716afc443aa3b3
Autor:
Timothy S. Heuer, Richard Ventura, Kasia Mordec, Julie Lai, Marina Fridlib, Douglas Buckley, George Kemble
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 51-62 (2017)
Palmitate, the enzymatic product of FASN, and palmitate-derived lipids support cell metabolism, membrane architecture, protein localization, and intracellular signaling. Tubulins are among many proteins that are modified post-translationally by acyla
Externí odkaz:
https://doaj.org/article/6f1c25fe440a4d5bb962bf5f6a378714
Autor:
Richard Ventura, Kasia Mordec, Joanna Waszczuk, Zhaoti Wang, Julie Lai, Marina Fridlib, Douglas Buckley, George Kemble, Timothy S. Heuer
Publikováno v:
EBioMedicine, Vol 2, Iss 8, Pp 808-824 (2015)
Inhibition of de novo palmitate synthesis via fatty acid synthase (FASN) inhibition provides an unproven approach to cancer therapy with a strong biological rationale. FASN expression increases with tumor progression and associates with chemoresistan
Externí odkaz:
https://doaj.org/article/28834e3476c148f1a56469f98d334506
Autor:
Camila Manrique-Acevedo, George Kemble, Douglas Buckley, Elizabeth J. Parks, Ayman H. Gaballah, Ghassan M. Hammoud, Majid M. Syed-Abdul, William McCulloch, Kimberlee Bingham
Publikováno v:
Hepatology. 72:103-118
Background and aims Elevated hepatic de novo lipogenesis (DNL) is a key distinguishing characteristic of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis. In rodent models of NAFLD, treatment with a surrogate of TVB-2640, a p
Autor:
Allan S. Wagman, George Kemble, Gregory Duke, Marie O'Farrell, William McCulloch, Timothy S. Heuer, Douglas Buckley
Publikováno v:
Pharmacology & Therapeutics. 177:23-31
Decades of preclinical and natural history studies have highlighted the potential of fatty acid synthase (FASN) as a bona fide drug target for oncology. This review will highlight the foundational concepts upon which this perspective is built. Publis
Autor:
Douglas Buckley, Timothy S. Heuer, Julie Lai, George Kemble, Kasia Mordec, Richard Benn Abegania Ventura, Marina Fridlib
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 51-62 (2017)
EBioMedicine
EBioMedicine
Palmitate, the enzymatic product of FASN, and palmitate-derived lipids support cell metabolism, membrane architecture, protein localization, and intracellular signaling. Tubulins are among many proteins that are modified post-translationally by acyla
Autor:
Joanna Waszczuk, Marina Fridlib, Zhaoti Wang, Kasia Mordec, Douglas Buckley, Richard Benn Abegania Ventura, Julie Lai, George Kemble, Timothy S. Heuer
Publikováno v:
EBioMedicine
EBioMedicine, Vol 2, Iss 8, Pp 808-824 (2015)
EBioMedicine, Vol 2, Iss 8, Pp 808-824 (2015)
Inhibition of de novo palmitate synthesis via fatty acid synthase (FASN) inhibition provides an unproven approach to cancer therapy with a strong biological rationale. FASN expression increases with tumor progression and associates with chemoresistan
Publikováno v:
Journal of Hepatology. 66:S99-S100
Publikováno v:
Canadian Journal of Criminology. 40:21-25
Autor:
Timothy S. Heuer, Richard Benn Abegania Ventura, Douglas Buckley, Julie Lai, George Kemble, Claudia Rubio, Joanna Waszczuk, Glenn Hammonds, Marie O' Farrell
Publikováno v:
Cancer Research. 76:4743-4743
Tumor cells have an increased dependence on FASN-synthesized palmitate compared to non-tumor cells, which obtain many of their required lipids from the extracellular milieu. Palmitate and palmitate-derived lipids comprise diverse cellular components